Knowledge rate of Dentists Regarding Dental Consideration of Bisphosphonate Drug User Patients

Hajmohammadi, Emran; Sattarzadeh, Sahand; Amani, Firouz

doi:10.5455/jrmds.2015338

Cited by 7 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Meanwhile, when patients were questioned about the medical conditions for which bisphosphonates are used, a notable percentage accurately identified osteoporosis (41.8%) and cancer (13.5%) as common indications. These findings align with a study conducted by Hajmohammadi E et al [28], involving 116 dentists, where 64.7% of participants correctly identified osteoporosis treatment.…”

Section: Discussionsupporting

confidence: 91%

Awareness of Medication-Related Osteonecrosis of the Jaws Amongst Patients on Antiresorptive and Antiangiogenic Medications

Assari,

Alanazi,

Mubarak Algharbi

et al. 2024

Cureus

View full text Add to dashboard Cite

BackgroundMedication-related osteonecrosis of the jaws (MRONJ) is a rare but severe condition that has garnered increasing attention in recent years. It primarily affects individuals undergoing treatment with antiresorptive and antiangiogenic medications, such as bisphosphonates and denosumab, commonly prescribed for osteoporosis and cancer-related bone metastases. Therefore, the present study aimed to assess awareness and understanding of MRONJ among patients receiving antiresorptive and antiangiogenic medications. MethodsA cross-sectional survey was conducted among 110 patients receiving antiresorptive and antiangiogenic medications in a clinical setting. Participants were given a structured questionnaire to assess their awareness of MRONJ. The questionnaire covered aspects such as MRONJ, bisphosphonate usage, and awareness of the condition's potential complications. Demographic information was also collected. Chisquare and Fisher's tests were performed using SPSS statistical software. ResultsIn terms of gender distribution, 63.6% of the participants were female. Concerning age distribution, the majority (43.6%) fell within the 21 to 40 age group, whereas only 5.5% were aged over 60. Regarding educational attainment, a substantial majority (58.2%) of the participants held a bachelor's degree. The study findings reveal that a considerable proportion (35.5%) of participants possess awareness regarding jaw osteonecrosis, and this association is statistically significant (p=0.002). A substantial number of participants administered the medication orally (30.9%), while others utilized various administration routes, including injection (IV and others) (40%), and this difference was also statistically significant (p=0.001). Most participants took bisphosphonates for osteoporosis (41.8%) or cancer (13.6%), both statistically significant (p<0.01). Gender had no significant impact (p>0.01), but age showed potential associations (p=0.07 for awareness, p=0.003 for medication use). Educational backgrounds had no significant link, except for bisphosphonate usage (p<0.01) and side effects reporting (p<0.01). ConclusionNotably, a small percentage of participants demonstrated awareness of this condition, indicating a need for continued education and awareness campaigns. Further research and interventions may be warranted to address the specific needs of different age groups and educational backgrounds in promoting safe and effective medication management.

show abstract

Section: Discussionsupporting

confidence: 91%

Awareness of Medication-Related Osteonecrosis of the Jaws Amongst Patients on Antiresorptive and Antiangiogenic Medications

Assari,

Alanazi,

Mubarak Algharbi

et al. 2024

Cureus

View full text Add to dashboard Cite

show abstract

“…A study correlating knowledge about bisphosphonates and the age of the dental surgeons indicated that professionals with less than 30 years had a higher level of knowledge on the topic when compared to professionals with older age, which, in turn, may be related to the updating of knowledge in recently graduated professionals, corroborating the data of the present work ( Hajmohammadi et al, 2015 ).…”

Section: Discussionsupporting

confidence: 88%

Assessing dental surgeons' understanding of bisphosphonates: Implications for patient health in oral surgery

Rocha Cortez Teles de Alencar,

Ribeiro Paulino,

Andrea Luna Martinis de Alencar

et al. 2024

The Saudi Dental Journal

View full text Add to dashboard Cite

“…Hajmohammadi et al have found that only 20% have good knowledge of the high risk procedures on dental patients taking BP, and 50.9% have just moderate knowledge. 16 Gonzales et al report that most participants in their study would avoid invasive procedures on patients taking any form of BP. 17 Rosella et al reported that dental students' knowledge about how invasive dental treatment might be carried out in patients under therapy was not adequate.…”

Section: Discussionmentioning

confidence: 98%

Bisphosphonate-associated Osteonecrosis of the Jaws: a Survey of the Level of Knowledge of Dentists about the Risks of Bisphosphonate Therapy

et al. 2019

View full text Add to dashboard Cite

Introduction: Bisphosphonate-associated osteonecrosis of the jaws (BAONJ) is a side effect of treatment with bisphosphonate (BP). Reports of this complication have increased recently. Aim: To evaluate the level of knowledge of dentists from Plovdiv, Bulgaria, about possible complications of bisphosphonate therapy of patients in dental practice. Materials and methods: Three hundred and twenty-three dental practitioners from Plovdiv, Bulgaria, took part in an anonymous survey containing 25 questions, designed to evaluate the knowledge of dentists about the complications of BP therapy. Results: Oral and maxillofacial surgeons have the best knowledge about the indications and side effects of BP therapy, while dentists with a specialty in Pediatric Dentistry and General Dentistry have insufficient knowledge. Of the respondents, 17.03% are absolutely uninformed about BP and their side effects, and 1/2 declare that they have never had a patient with complications from BP therapy in their practice, probably due to a lack of awareness of the problem. Approximately half of the dentists we surveyed agree to carry out prophylactic examinations of patients receiving BP and know what the prophylactic examination includes. Only 15.48% of the respondents have correctly responded that in order to be treated as clinically healthy, patients should have stopped taking BP for more than 10 years. Conclusion: With the exception of specialists in Oral and Maxillofacial Surgery, dental practitioners in Plovdiv and the region are poorly informed about the complications associated with BP therapy. Therefore, efforts must be made to make these dentists better informed about BAONJ, especially about the methods and means of preventing this condition.

show abstract

Knowledge rate of Dentists Regarding Dental Consideration of Bisphosphonate Drug User Patients

Cited by 7 publications

References 0 publications

Awareness of Medication-Related Osteonecrosis of the Jaws Amongst Patients on Antiresorptive and Antiangiogenic Medications

Awareness of Medication-Related Osteonecrosis of the Jaws Amongst Patients on Antiresorptive and Antiangiogenic Medications

Assessing dental surgeons' understanding of bisphosphonates: Implications for patient health in oral surgery

Bisphosphonate-associated Osteonecrosis of the Jaws: a Survey of the Level of Knowledge of Dentists about the Risks of Bisphosphonate Therapy

Contact Info

Product

Resources

About